No Data
No Data
Press Release: Harrow To Report Third Quarter 2024 Financial Results After Market Close on November 13, 2024
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
Lateral Investment Management to Attend SuperReturn North America 2024
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Raises Target Price to $73
Harrow Health: Promising Growth Trajectory and Compelling Investment Opportunity
B. Riley Adjusts Price Target on Harrow to $73 From $50, Maintains Buy Rating
loading...
loading...
No Data
No Data